Cite
HARVARD Citation
Low, M. et al. (2013). High‐dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC‐3) results in high first‐cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia. Internal medicine journal. 43 (3), pp. 294-297. [Online].